For Immediate Release: Oct. 16, 2015
For media inquiries, please contact Julia Gunther at [email protected] or 215-446-6896. Visit our newsroom.
PHILADELPHIA — The American Association for Cancer Research (AACR) will be honored as the 2015 Beacon of Hope Award recipient by Susan G. Komen Philadelphia at Komen Philadelphia’s 14th annual Pink Tide Ball this Saturday, Oct. 17. Margaret Foti, PhD, MD (hc), chief executive officer of the AACR, will accept the award on the AACR’s behalf.
“In every sense of the word, the AACR has been a true partner in the Komen Philadelphia mission, and we are thrilled to recognize them for being so,” said Elaine I. Grobman, chief executive officer of Komen Philadelphia. “Their ceaseless dedication to breast cancer research allows us to forge ahead in empowering our communities with education, support, and connections to vital breast cancer services including treatment options that, every day, are getting more and more effective because of the work of the AACR. The organization and Dr. Foti embody the tremendous hope that makes us all confident that one day every person diagnosed with breast cancer is certain to survive it.”
“We at the AACR are deeply honored to receive this award from Susan G. Komen Philadelphia, an organization that has been so active and effective in the fight against breast cancer,” said Foti. “Komen has been a vitally important collaborator with the AACR for many years, both here in Philadelphia and at a national level. The AACR believes very strongly in the importance of collaboration, for if we are to accelerate the pace of progress against cancer, we must come together as individuals and as organizations to take concerted action against this foe. Because of partnerships like the one shared by Komen and the AACR, great progress has been made in the prevention and cure of breast cancer.”
Headquartered in Philadelphia, the AACR is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. Its membership comprises more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 101 countries.
The organization convenes more than 30 national and international conferences and educational workshops each year, the largest of which is the AACR Annual Meeting. This year’s Annual Meeting, hosted April 18-22 in Philadelphia, attracted nearly 19,300 attendees. To accelerate the dissemination of new research findings among scientists and others dedicated to the conquest of cancer, the AACR publishes eight peer-reviewed scientific journals as well as a magazine for cancer survivors, patients, and their caregivers. In addition, the organization funds meritorious research directly as well as in cooperation with numerous cancer organizations, and it actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
Along with the Cancer Therapy & Research Center at UT Health Science Center San Antonio and Baylor College of Medicine, the AACR is a sponsor of the San Antonio Breast Cancer Symposium (SABCS), an annual five-day conference that features the latest advances in basic, translational, and clinical breast cancer research and brings together more than 8,000 researchers and advocates from over 90 countries.
In addition to its national and international initiatives, the AACR is active locally, including as a sponsor of the Philadelphia Rock ‘n’ Roll Half Marathon, to be held Oct. 31, 2015.
# # #
Follow us: Cancer Research Catalyst https://blog.aacr.org; Twitter @AACR; and Facebook https://www.facebook.com/aacr.
For AACR information, visit Fast Facts.
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 101 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops, the largest of which is the AACR Annual Meeting with almost 19,300 attendees. In addition, the AACR publishes eight prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit www.AACR.org.
